Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Inventory (2016 - 2025)

Prestige Consumer Healthcare has reported Inventory over the past 15 years, most recently at $163.6 million for Q4 2025.

  • For Q4 2025, Inventory rose 7.97% year-over-year to $163.6 million; the TTM value through Dec 2025 reached $163.6 million, up 7.97%, while the annual FY2025 figure was $147.7 million, 6.48% up from the prior year.
  • Inventory for Q4 2025 was $163.6 million at Prestige Consumer Healthcare, up from $159.0 million in the prior quarter.
  • Over five years, Inventory peaked at $169.8 million in Q2 2023 and troughed at $105.5 million in Q2 2021.
  • A 5-year average of $142.6 million and a median of $150.1 million in 2023 define the central range for Inventory.
  • Biggest five-year swings in Inventory: surged 49.16% in 2022 and later decreased 14.44% in 2024.
  • Year by year, Inventory stood at $106.3 million in 2021, then surged by 49.16% to $158.5 million in 2022, then dropped by 6.24% to $148.6 million in 2023, then grew by 1.94% to $151.5 million in 2024, then increased by 7.97% to $163.6 million in 2025.
  • Business Quant data shows Inventory for PBH at $163.6 million in Q4 2025, $159.0 million in Q3 2025, and $153.1 million in Q2 2025.